You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Claims for Patent: 5,854,382

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 5,854,382

Title:	Bioresorbable compositions for implantable prostheses
Abstract:	Crosslinked compositions formed from a water-insoluble copolymer are disclosed. These compositions are copolymers having a bioresorbable region, a hydrophilic region and at least two crosslinkable functional groups per polymer chain. These compositions are able to form hydrogels in aqueous environments when crosslinked. These hydrogels are good sealants for implantable prostheses when in contact with an aqueous environment. In addition, such hydrogels can be used as delivery vehicles for therapeutic agents.
Inventor(s):	Loomis; Gary L. (Morristown, NJ)
Assignee:	Meadox Medicals, Inc. (Oakland, NJ)
Application Number:	08/914,130
Patent Claims:	1. A covalently crosslinkable composition comprising a water-insoluble copolymer having (i) a bioresorbable region; (ii) a hydrophilic region; and (iii) a plurality of crosslinkable functional groups per polymer chain. 2. The composition of claim 1, wherein said copolymer forms a stable aqueous emulsion. 3. The composition of claim 1, wherein the ratio of said bioresorbable region to said hydrophilic region is from about 10:1 to about 1:1 on a percent by weight basis. 4. The composition of claim 1, wherein the relative properties and proportions of said bioresorbable region and said hydrophilic region are selected to render said composition insoluble in water. 5. The composition of claim 1, wherein said bioresorbable region is hydrophobic. 6. The composition of claim 1, wherein said bioresorbable region has hydrophilic character without rendering the polymer water-soluble. 7. The composition of claim 1, wherein said bioresorbable region is hydrolytically and/or enzymatically cleavable. 8. The composition of claim 1, wherein said bioresorbable region is selected from the group consisting of poly(esters), poly(hydroxy acids), poly(lactones), poly(amides), poly(ester-amides), poly (amino acids), poly(anhydrides), poly(orthoesters), poly(carbonates), poly(phosphazines), poly(phosphoesters), poly(thioesters), polysaccharides and mixtures thereof. 9. The composition of claim 1, wherein said bioresorbable region is a poly(hydroxy) acid. 10. The composition of claim 9, wherein said poly(hydroxy) acid is formed from material selected from the group consisting of polylactic acid, polyglycolic acid, polycaproic acid, polybutyric acid, polyvaleric acid and copolymers and mixtures thereof. 11. The composition of claim 1, wherein said hydrophilic region is selected from the group consisting of polyethers, polyalkylene oxides, polyols, poly(vinylpyrrolidine), poly(vinyl alcohol), poly(alkyl oxazolines), polysaccharides, carbohydrates, peptides, proteins and copolymers and mixtures thereof. 12. The composition of claim 1, wherein said hydrophilic region forms an excretable and/or metabolizable fragment. 13. The composition of claim 1, wherein said hydrophilic region is a poly(alkylene) oxide. 14. The composition of claim 13, wherein said poly(alkylene) oxide is selected from the group consisting of poly(ethylene) oxide, poly(propylene) oxide and mixtures and copolymers thereof. 15. The composition of claim 1, wherein said plurality of crosslinkable functional groups are olefinically unsaturated groups. 16. The composition of claim 15, wherein at least one of said olefinically unsaturated functional groups is positioned at a terminus of said polymer chain. 17. The composition of claim 15, wherein said olefinically unsaturated functional groups are selected from the group consisting of acrylates, methacrylates, butenoates, maleates, allyl ethers, allyl thioesters and N-allyl carbamates. 18. The composition of claim 1 being crosslinked by high energy or thermal radiation. 19. The composition of claim 1 being crosslinked by visible light. 20. The composition of claim 1 further including a free radical initiator. 21. The composition of claim 20, wherein said free radical initiator is a peroxide. 22. The composition of claim 20, wherein said free radical initiator is an azo compound. 23. The composition of claim 1, wherein said copolymer is crosslinked in an aqueous medium. 24. The composition of claim 23, wherein a crosslinked polymer forms a hydrogel. 25. The composition of claim 23, wherein said hydrophilic region is water-swellable. 26. The composition of claim 24, wherein said hydrogel is useful as a coating for a medical device. 27. The composition of claim 24, wherein said hydrogel is useful as a drug or bio-active agent delivery vehicle. 28. The composition of claim 27, wherein said drug or bio-active agent is selected from the group consisting of thrombo-resistant agents, antibiotic agents, anti-tumor agents, antiviral agents, anti-angiogenic agents, angiogenic agents, anti-inflammatory agents, cell cycle regulating agents and chemically modified equivalents and combinations thereof. 29. The composition of claim 28, wherein said drug or bio-active agent is selected from the group of thrombo-resistant agents consisting of heparin, heparin sulfate, hirudin, hyaluronic acid, chondroitin sulfate, dermatan sulfate, keratan sulfate, lytic agents, urokinase, streptokinase, and chemically modified equivalents and combinations thereof. 30. The composition of claim 28, wherein said drug or bio-active agent is selected from the group of antibiotic agents consisting of penicillins, cephalosporins, vancomycins, aminoglycosides, quinolones, polymyxins, erthromycins, tetracyclines, chloramphenicols, clindamycins, lincomycins, sulfonamides, and chemically modified equivalents and combinations thereof. 31. The compositions of claim 28, wherein said drug or bio-active agent is selected from the group of antibiotic agents consisting of paclitaxel, mechlorethamine, chlorambucil, cyclophosphamide, melphalan, ifosfamide, methotrexate, 6-mercaptopurine, 5-fluorouracil, cytarabine, vinblastine, vincristine, etoposide, doxorubicin, daunomycin, bleomycin, mitomycin, carmustine, lomustine, cisplatin, interferon, asparaginase, tamoxifen, flutamide and chemically modified equivalents and combinations thereof. 32. The compositions of claim 28, wherein said drug or bio-active agent is selected from the group of anti-viral agents consisting of amantadines, rimantadines, ribavirins, idoxuridines, vidarabines, trifluridines, acyclovirs, ganciclovirs, zidovudines, foscarnets, interferons, and chemically modified equivalents and combinations thereof.

Details for Patent 5,854,382

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Microbix Biosystems Inc.	KINLYTIC	urokinase	For Injection	021846	01/16/1978	⤷ Try a Trial	2039-03-29
Recordati Rare Diseases, Inc.	ELSPAR	asparaginase	For Injection	101063	01/10/1978	⤷ Try a Trial	2039-03-29
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.